| Product Code: ETC13130984 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Non-Small Cell Lung Cancer Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Non-Small Cell Lung Cancer Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle |
3.4 North America Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces |
3.5 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F |
3.9 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 North America Non-Small Cell Lung Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Non-Small Cell Lung Cancer Diagnostics Market Trends |
6 North America Non-Small Cell Lung Cancer Diagnostics Market, 2021 - 2031 |
6.1 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021 - 2031 |
6.1.3 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021 - 2031 |
6.1.4 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031 |
6.1.5 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Reagents & Kits, 2021 - 2031 |
6.2.3 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Instruments And Services & Software's, 2021 - 2031 |
6.3 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Imaging Test, 2021 - 2031 |
6.3.3 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Molecular Test, 2021 - 2031 |
6.3.4 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Biopsy, 2021 - 2031 |
6.3.5 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Sputum Cytology, 2021 - 2031 |
6.3.6 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Thoracentesis, 2021 - 2031 |
6.3.7 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Immunohistochemistry, 2021 - 2031 |
6.3.8 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.4.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.4.3 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Clinical Laboratories, 2021 - 2031 |
6.4.4 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Academics, 2021 - 2031 |
6.4.5 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Non-Small Cell Lung Cancer Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.2 Canada Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.2.3 Rest of North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Cancer Type, 2021 - 2031 |
7.3 North America Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
7.3.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.2 Canada Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3.3 Rest of North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.4 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.2 Canada Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.4.3 Rest of North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By Test, 2021 - 2031 |
7.5 North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.1 United States (US) Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.2 Canada Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.5.3 Rest of North America Non-Small Cell Lung Cancer Diagnostics Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 North America Non-Small Cell Lung Cancer Diagnostics Market Key Performance Indicators |
9 North America Non-Small Cell Lung Cancer Diagnostics Market - Export/Import By Countries Assessment |
10 North America Non-Small Cell Lung Cancer Diagnostics Market - Opportunity Assessment |
10.1 North America Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
10.3 North America Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10.4 North America Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F |
10.5 North America Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F |
11 North America Non-Small Cell Lung Cancer Diagnostics Market - Competitive Landscape |
11.1 North America Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here